Inflammation-related gene expression profiles of salivary extracellular vesicles in patients with head trauma.

Autor:	Cheng Y; Department of Medicine, Division of Hematology/Oncology, Rhode Island Hospital, Providence, RI, USA., Pereira M; Department of Medicine, Division of Hematology/Oncology, Rhode Island Hospital, Providence, RI, USA., Raukar NP; Department of Emergency Medicine, Mayo Clinic, Rochester, MN, USA., Reagan JL; Department of Medicine, Division of Hematology/Oncology, Rhode Island Hospital, Providence, RI, USA., Quesenberry M; Department of Medicine, Division of Hematology/Oncology, Rhode Island Hospital, Providence, RI, USA., Goldberg L; Department of Medicine, Division of Hematology/Oncology, Rhode Island Hospital, Providence, RI, USA., Borgovan T; Department of Medicine, Division of Hematology/Oncology, Rhode Island Hospital, Providence, RI, USA., LaFrance Jr WC; Department of Psychiatry and Neurology, Rhode Island Hospital, Providence, RI, USA., Dooner M; Department of Medicine, Division of Hematology/Oncology, Rhode Island Hospital, Providence, RI, USA., Deregibus M; Department of Medical Sciences, University of Turin, Torino TO, Italy., Camussi G; Department of Medical Sciences, University of Turin, Torino TO, Italy., Ramratnam B; Department of Medicine, Division of Infectious Diseases, Rhode Island Hospital, Providence, RI, USA., Quesenberry P; Department of Medicine, Division of Hematology/Oncology, Rhode Island Hospital, Providence, RI, USA.
Jazyk:	angličtina
Zdroj:	Neural regeneration research [Neural Regen Res] 2020 Apr; Vol. 15 (4), pp. 676-681.
DOI:	10.4103/1673-5374.266924
Abstrakt:	At present, there is no reliable biomarker for the diagnosis of traumatic brain injury (TBI). Studies have shown that extracellular vesicles released by damaged cells into biological fluids can be used as potential biomarkers for diagnosis of TBI and evaluation of TBI severity. We hypothesize that the genetic profile of salivary extracellular vesicles in patients with head trauma differs from that in uninjured subjects. Findings from this hypothesis would help investigate the severity of TBI. This study included 19 subjects, consisting of seven healthy controls who denied history of head trauma, six patients diagnosed with concussion injury from an outpatient concussion clinic, and six patients with TBI who received treatment in the emergency department within 24 hours after injury. Real-time PCR analysis of salivary extracellular vesicles in participants was performed using TaqMan Human Inflammation array. Gene expression analysis revealed nine upregulated genes in emergency department patients (LOX5, ANXA3, CASP1, IL2RG, ITGAM, ITGB2, LTA4H, MAPK14, and TNFRSF1A) and 13 upregulated genes in concussion clinic patients compared with healthy participants (ADRB1, ADRB2, BDKRB1, HRH1, HRH2, LTB4R2, LTB4R, PTAFR, CYSLTR1, CES1, KLK1, MC2R, and PTGER3). Each patient group had a unique profile. Comparison between groups showed that 15 inflammation-related genes had significant expression change. Our results indicate that inflammation biomarkers can be used for diagnosis of TBI and evaluation of disease severity. This study was approved by the Institutional Review Board on December 18, 2015 (approval No. 0078-12) and on June 9, 2016 (approval No. 4093-16). Competing Interests: None
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu